Venlafaxine
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)- Drug Class
- Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
- Mechanism of Action (MOA)
- Inhibits serotonin and norepinephrine reuptake (SNRI).
- Black Box Warning
- Increased suicidality in patients <25.
- Clinical Notes
- Depression, GAD, social anxiety, panic disorder. Dose-related increased blood pressure; pronounced discontinuation syndrome — taper carefully.
- Source
- FDA label
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Used for
Same family
Got a pharmacology lecture that covers Venlafaxine? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology